Holocene Advisors, LP - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Holocene Advisors, LP ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q1 2022$2,836,000
-28.0%
2,532,204
+2.8%
0.02%
-28.6%
Q4 2021$3,941,000
-23.8%
2,463,114
+15.2%
0.02%
-25.0%
Q3 2021$5,172,000
-16.3%
2,137,219
+9.6%
0.03%
-20.0%
Q2 2021$6,181,000
+62.3%
1,949,737
+72.5%
0.04%
+45.8%
Q1 2021$3,808,000
-38.0%
1,129,987
-34.1%
0.02%
-38.5%
Q4 2020$6,139,0001,714,9320.04%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Rubric Capital Management LP 16,756,120$18,767,0000.99%
Clearline Capital LP 3,058,596$3,426,0000.44%
SUVRETTA CAPITAL MANAGEMENT, LLC 9,142,067$10,239,0000.39%
DAFNA Capital Management LLC 1,096,513$1,228,0000.34%
Octagon Capital Advisors LP 1,000,000$1,120,0000.30%
Rock Springs Capital Management LP 6,230,275$6,978,0000.20%
Boxer Capital, LLC 2,250,000$2,520,0000.16%
Orbimed Advisors 7,109,954$7,963,0000.14%
Artal Group S.A. 1,500,000$1,680,0000.09%
SECTORAL ASSET MANAGEMENT INC 385,000$431,0000.09%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders